2022
Total Joint Arthroplasty Direct-to-Consumer Advertising by Medical Device Companies Lacks Patient Diversity
Rankin KA, Bahel A, Khunte A, Oris RJ, O'Connor MI, Wiznia DH. Total Joint Arthroplasty Direct-to-Consumer Advertising by Medical Device Companies Lacks Patient Diversity. Arthroplasty Today 2022, 16: 96-100. PMID: 35662990, PMCID: PMC9160652, DOI: 10.1016/j.artd.2022.04.010.Peer-Reviewed Original ResearchMovement is Life—Optimizing Patient Access to Total Joint Arthroplasty: Chronic Kidney Disease Disparities
Wiznia D, Nelson C, Harrington M. Movement is Life—Optimizing Patient Access to Total Joint Arthroplasty: Chronic Kidney Disease Disparities. Journal Of The American Academy Of Orthopaedic Surgeons 2022, 30: 1064-1068. PMID: 35427242, DOI: 10.5435/jaaos-d-21-00919.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseRate of CKDTotal joint arthroplastyKidney transplantKidney diseaseJoint arthroplastyEnd-stage kidney diseasePeriprosthetic joint infectionAfrican AmericansPostoperative readmissionsDiabetes mellitusArthroplasty candidatesJoint infectionHeart diseasePatient accessDisease disparitiesHispanic individualsDiseaseDisadvantaged populationsUnderserved communitiesAmerican adultsComplicationsHemodialysisPatientsArthroplasty
2021
Movement is Life—Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities
Wiznia DH, Morgan RC, Gibson D. Movement is Life—Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities. Journal Of The American Academy Of Orthopaedic Surgeons 2021, 30: 1011-1016. PMID: 34723921, DOI: 10.5435/jaaos-d-21-00427.Peer-Reviewed Original ResearchConceptsTotal joint arthroplastyHepatitis CJoint arthroplastyChronic hepatitis CHIV-positive patientsHepatitis C infectionInfectious disease specialistsLow complication rateNew HIV diagnosesPrimary care teamsHalf of individualsAfrican AmericansC infectionPostoperative complicationsComplication rateHIV diagnosisSurgical complicationsViral loadDisease specialistsComplex comorbiditiesTreatment modalitiesCare teamTreatment accessHigh riskVulnerable cohort